8-KThe WireRoutine
Bylaw Amendment
Filed Dec 15, 2023 · 2y ago · Accession 0001193125-23-296659
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Vanda Pharmaceuticals Inc.
- Ticker
- VNDA
- CIK
- 1347178
- Form type
- 8-K
- Filing date
- Dec 15, 2023
- Report date
- Dec 13, 2023
- Document
- d35023d8k.htm
- Size
- 344 KB